The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 11 - 20 of 282
Guidelines for HIV Prevention, Testing, and Treatment of HIV in Zimbabwe, 2022
The Zimbabwe Ministry of Health has created these guidelines to advise both private and public sector stakeholders on realigning and their initiatives to provide the best HIV care to clients in an effort to end AIDS by 2030. These guidelines are in line with the new Zimbabwe Health Sector HIV and STI Strategy: 2021-2025.
Technical Guidance on PrEP for Persons at Substantial Risk of HIV in Uganda, 2022
The Ministry of Health has created these technical guidelines to serve as guides for healthcare workers and stakeholders serving populations most at risk of acquiring HIV. These guidelines detail how to provide these populations with PrEP.
Recomendaciones Sobre la Profilaxis Pre-Exposición para la Prevención de la Infección por VIH en España, 2023
Estas recomendaciones destacan el estado del VIH, el impacto potencial de la PrEP y la adherencia a la PrEP en España.
Value Chain Situation Analysis for CAB PrEP – Overview Guide
This tool can be used by policymakers or others supporting policy development for CAB PrEP (e.g., nongovernmental organizations, donors) to conduct an analysis to assess the existing situation for the introduction of the new product. The guide facilitates a structured process in three steps to support initial planning for CAB PrEP introduction: data collection, stakeholder…
Consolidated Guidelines for the Prevention and Treatment of HIV and AIDS in Uganda, 2020
Guidelines for the Prevention and Treatment of HIV from the Ministry of Health in Uganda. PrEP is recommended for HIV-negative people at substantial risk of acquiring HIV infection.
Dual Prevention Pill: Market Preparation and Introduction Strategy
This strategy, updated in August 2023, is intended for donors, governments, implementing partners and civil society to inform priorities and planning for DPP rollout. The strategy describes activities required to build a cohesive body of evidence and recommends an approach to DPP introduction to focus efforts. Where possible, activities will be embedded into existing programs…
Demand Creation/Marketing, Financing & Costing, Normative Guidance/Policies, Research, Supply Chain Management
Deep Dive Review of Modelling Long Acting PrEP Meeting Summary
In March 2023, the Bill and Melinda Gates Foundation convened modellers looking into the impact, costs, and/or cost effectiveness of cabotegravir (CAB) for PrEP in low and middle income countries. This meeting summary provides an overview of 11 models as well as key insights emerging from the models and knowledge gaps.
Consolidated Guidelines on Person-centred HIV Strategic Information: Strengthening routine data for impact
These guidelines from the WHO, published in July 2022, focus on the collection and use of person-centred data across the HIV cascade – from prevention, testing and treatment to longer-term health care – building upon 2017 and 2020 strategic information guidelines. The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen…
Monitoring & Evaluation
Report: Formative research on CAB for PrEP in Eswatini
The goal of this study was to assess access needs, product acceptability, values, and preferences for the new PrEP method. This activity was a collaboration between EpiC and MOSAIC, and included adolescent girls and young women, men who have sex with men, people who inject drugs, female sex workers, pregnant and breastfeeding populations, and transgender…
Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction Report
This report was from the BioPIC Think Tank, Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction. As new HIV prevention products move closer to entering the market, there is an opportunity to design choice-based programs that apply lessons and successes from HIV and FP…